GLUE

Monte Rosa Therapeutics (GLUE)

About Monte Rosa Therapeutics (GLUE)

Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Details

Daily high
$17.81
Daily low
$16.60
Price at open
$16.66
52 Week High
$19.17
52 Week Low
$3.50
Market cap
1.1B
Dividend yield
0.00%
Volume
482,319
Avg. volume
1.2M
P/E ratio
57.76

Monte Rosa Therapeutics News

Details

Daily high
$17.81
Daily low
$16.60
Price at open
$16.66
52 Week High
$19.17
52 Week Low
$3.50
Market cap
1.1B
Dividend yield
0.00%
Volume
482,319
Avg. volume
1.2M
P/E ratio
57.76